Microbiome, innate immunity, and esophageal adenocarcinoma.
Journal: Clin Lab Med
Date: 2014 Dec
Major Program(s) or Research Group(s): PLCO
PubMed ID: 25439272
PMC ID: PMC4254553
Abstract: With the development of culture-independent technique, a complex microbiome has been established and described in the distal esophagus. The incidence of esophageal adenocarcinoma (EAC) has increased dramatically in the United States. Studies documenting an altered microbiome associated with EAC and its precedents suggest that dysbiosis may be contributing to carcinogenesis, potentially mediated by interactions with toll-like receptors. Investigations attempting to associate viruses with EAC have not been as consistent. Currently available data are cross-sectional and therefore cannot prove causal relationships. Prospectively, microbiome studies open a new avenue to the understanding of the etiology and pathogenesis of reflux disorders and EAC.